Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Porin Makarić"'
Autor:
Martina Rojnic Kuzman, Dina Bosnjak Kuharic, Ivana Kekin, Porin Makaric, Zoran Madzarac, Ana Koricancic Makar, Suzan Kudlek Mikulic, Zarko Bajic, Petra Bistrovic, Dora Bonacin, Zeljka Vogrinc
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
Background: Antipsychotic-induced weight gain and metabolic abnormalities are one of the major challenges in the treatment of psychosis, contributing to the morbidity, mortality and treatment non-adherence. Different approaches were used to counterac
Externí odkaz:
https://doaj.org/article/1bcc2b439b5d4513941adf9cf6ee52fd
Autor:
Marko Ćurković, Porin Makarić, Arian Bljakčori, Senka i Repovečk, Jasna Mesarić, Petrana Brečić
Publikováno v:
Liječnički vjesnik, Vol 145, Iss 11-12, Pp 355-361 (2023)
Bolnički dio sustava skrbi za psihičko zdravlje izložen je svim izazovima sigurnosti kao i drugi dijelovi bolničkoga zdravstvenog sustava, no mimo njih izložen je i dodatnim, jedinstvenim izazovima sigurnosti, od kojih je jedan svakako povezan s
Externí odkaz:
https://doaj.org/article/692909cd7fa44c82bf333ba7c07bf5bf
Autor:
Ana Koricancic Makar, Dina Bošnjak Kuharić, Drazenka Ostojic, Ivana Kekin, Zarko Bajic, Martina Rojnic Kuzman, Maja Zivkovic, Zoran Madzarac, Porin Makarić, Ante Silić
Publikováno v:
Journal of Clinical Psychopharmacology. 40:366-372
Background One of the main goals in the treatment of first-episode psychosis (FEP) is achieving functional remission. This study aims to analyze whether initial neurocognitive status and the use of specific pharmacological and psychosocial treatment
Autor:
Porin Makarić, Martina Rojnic Kuzman, Nikola Prpic, Dina Bošnjak Kuharić, Nada Bozina, Zarko Bajic, Tamara Bozina, Linda Rossini Gajsak, Lana Ganoci, Ivana Kekin
Publikováno v:
European Psychiatry. 61:88-96
INTRODUCTION: We analyzed the association of cannabinoid receptor CNR1 genotypes with changes in neurocognitive performance in patients with first-episode psychosis (FEP) after 18 months of treatment. Our secondary aim was to analyze the association
Autor:
Petrana Brečić, Dina Bošnjak Kuharić, Martina Rojnic Kuzman, Ivana Kekin, Aleksandar Savić, Ante Silić, Iva Lukacevic Lovrencic, Zarko Bajic, Drazenka Ostojic, Porin Makarić
Publikováno v:
Journal of the International Neuropsychological Society. 25:165-173
Objectives: The aim of our study was to assess the differences in facial emotional recognition (FER) between patients with first-episode psychosis (FEP), patients with multi-episode schizophrenia (SCH), and healthy controls (HC) and to find possible
Autor:
Linda Rossini Gajšak, Željka Vogrinc, Mirela Čelić, null Ružić, Dina Bošnjak, null Kuharić, Marija Bošković, Ana Koričančić, null Makar, Porin Makarić, Vesna Ermakora, Ivana Kekin, Žarko Bajić, Martina Rojnić Kuzman
Publikováno v:
Croatian Medical Journal
Volume 62
Issue 1
Volume 62
Issue 1
Aim To analyze the difference in the salivary cortisol response to psychosocial stress between the patients with the first episode of psychosis (FEP) and the control group. Methods We performed a cross-sectional analysis of the baseline measurements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a135566365f09b7cc01ee15ea42cff
https://www.bib.irb.hr/1135578
https://www.bib.irb.hr/1135578
Autor:
Ante Silić, Maja Zivkovic, Drazenka Ostojic, Julian Beezhold, Iva Lukacevic Lovrencic, Zarko Bajic, Martina Rojnic Kuzman, Porin Makarić, Linda Rossini Gajsak, Ivana Kekin, Dina Bošnjak Kuharić
Publikováno v:
Psychiatry research. 304
Neurocognitive symptoms exert the most influence on treatment outcomes over the course of schizophrenia, starting from the first-episode of psychosis (FEP) onwards. Our aim was to analyze the neurocognitive status of FEP compared to healthy controls
Autor:
Dina Bošnjak Kuharić, Martina Rojnic Kuzman, Lana Ganoci, Ivana Kekin, Porin Makarić, Nikola Prpic, Tamara Bozina, Nada Bozina
Our aim was to analyze the association of HSPA1B genotypes and treatment response measured by the changes of psychopathology and neurocognitive symptoms in patients with first- episode psychosis (FEP) after 18 months of treatment. A sample of 159 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675f7f3e1a2af77feb5c59843c4b6d9b
https://www.bib.irb.hr/1070901
https://www.bib.irb.hr/1070901
Publikováno v:
Medicus
Volume 29
Issue 2 COVID-19
Volume 29
Issue 2 COVID-19
Pandemija COVID-19 svojim utjecajem na tjelesno zdravlje te kao potencijalna životna ugroza ima značajne reperkusije na mentalno zdravlje u smislu posljedičnog psihološkog distresa i pojave simptoma psihičkih poremećaja. Navedeni utjecaj je dod
Publikováno v:
European Neuropsychopharmacology. 29:S463-S464